please find enclosed herewith the Monitoring Agency Report dated July 31, 2025 issued by ICICI Bank Limited, Monitoring Agency in respect of utilization of proceeds of the initial public offer of the Company for the quarter ended June 30, 2025
POLICYBZR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
PB Fintech Limited has submitted the quarterly Monitoring Agency Report issued by ICICI Bank for the quarter ended June 30, 2025, confirming utilization of IPO proceeds as per disclosed objects with no deviations. The original 2021 IPO raised ₹57,097.15 million, of which ₹36,126.85 million was allocated across five objects. During Q1 FY26, the company deployed ₹3,901.62 million, including a ₹3,499.50 million strategic investment in compulsory convertible preference shares (CCPS) of PB Healthcare Services Private Limited. Cumulative utilization stood at ₹31,984.57 million, leaving ₹4,142.28 million unutilized, parked in fixed deposits with Axis Bank, HDFC Bank, Kotak Bank, and Punjab National Bank. The brand enhancement object (₹15,000M) and general corporate purposes (₹7,626.85M) are fully utilized, while consumer growth initiatives, strategic investments, and international expansion remain partially deployed with revised timelines extended to March 31, 2026.
No negative surprise for shareholders — the monitoring agency confirms no deviation from stated objectives. The strategic investment in PB Healthcare signals continued expansion into health-tech, which could be viewed positively, though the reallocation of funds from international expansion to domestic offline growth suggests a strategic pivot. The extension of timeline to March 31, 2026 is routine for ongoing deployment and not a red flag.